International Journal of Applied and Basic Medical Research

ORIGINAL ARTICLE
Year
: 2015  |  Volume : 5  |  Issue : 1  |  Page : 25--30

Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women


Setu Rathod1, Sunil K Samal1, Purna C Mahapatra1, Sunita Samal2 
1 Department of Obstetrics and Gynaecology, SCB Medical College, Cuttack, Odisha, India
2 Department of Obstetrics and Gynaecology, Mahatma Gandhi Medical College and Research Institute, Puducherry, India

Correspondence Address:
Setu Rathod
IV-D, Type 2 Staff Quarters, Mahatma Gandhi Medical College, Pillaiyarkuppam, Puducherry - 607 402
India

Objectives: The objective of the present study is to compare the safety and efficacy of ferric carboxymaltose (FCM), intravenous (IV) iron sucrose and oral iron in the treatment of post = partum anemia (PPA). Materials and Methods: A total of 366 women admitted to SCB Medical College, Cuttack between September 2010 and August 2012 suffering from PPA hemoglobin (Hb) <10 g/dL were randomly assigned to receive either oral iron or IV FCM or iron sucrose. FCM, IV iron sucrose, and oral iron were given as per the protocol. Changes in hemoglobin (Hb) and serum ferritin levels at 2 and 6 weeks after treatment were measured and analyzed using ANOVA. Adverse effects to drug administration were also recorded. Results: A statistically significant increase in Hb and serum ferritin level were observed in all three groups, but the increase in FCM group was significantly higher (P < 0.0001) than conventional iron sucrose and oral iron group. The mean increase in Hb after 2 weeks was 0.8, 2.4, and 3.2 g/dL and 2.1, 3.4, and 4.4 g/dL at 6 weeks in oral iron, iron sucrose and FCM groups, respectively. The mean increase in serum ferritin levels after 2 weeks was 2.5, 193.1, and 307.1 and 14.2, 64, and 106.7 ng/mL after 6 weeks in oral iron, iron sucrose and FCM groups, respectively. Adverse drug reactions were significantly less (P < 0.001) in FCM group when compared with other two groups. Conclusion: Ferric carboxymaltose elevates Hb level and restores iron stores faster than IV iron sucrose and oral iron, without any severe adverse reactions. There was better overall satisfaction reported by the patients who received FCM treatment.


How to cite this article:
Rathod S, Samal SK, Mahapatra PC, Samal S. Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women.Int J App Basic Med Res 2015;5:25-30


How to cite this URL:
Rathod S, Samal SK, Mahapatra PC, Samal S. Ferric carboxymaltose: A revolution in the treatment of postpartum anemia in Indian women. Int J App Basic Med Res [serial online] 2015 [cited 2021 Sep 28 ];5:25-30
Available from: https://www.ijabmr.org/article.asp?issn=2229-516X;year=2015;volume=5;issue=1;spage=25;epage=30;aulast=Rathod;type=0